Cold & Cough Remedies (Pharmacies) - Ivory Coast

  • Ivory Coast
  • Revenue in the Cold & Cough Remedies market is projected to reach US$74.39m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 6.04%, resulting in a market volume of US$94.05m by 2028.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.51 are generated in 2024.

Key regions: United Kingdom, South Korea, Europe, Japan, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Ivory Coast has been experiencing significant growth in recent years.

Customer preferences:
In Ivory Coast, customers have shown a growing demand for cold and cough remedies from pharmacies. This can be attributed to several factors. Firstly, there is an increasing awareness among the population about the importance of maintaining good health and taking preventive measures against illnesses. As a result, more people are seeking over-the-counter remedies for common cold and cough symptoms. Secondly, the convenience of purchasing these remedies from pharmacies, which are easily accessible in urban areas, has contributed to the growing demand. Customers prefer the convenience of being able to buy these remedies without a prescription and without having to visit a doctor.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Ivory Coast is the rise in sales of natural and herbal remedies. Customers are increasingly opting for natural alternatives to traditional cold and cough medicines, as they believe these remedies are safer and have fewer side effects. This trend is in line with the global shift towards natural and organic products in the healthcare industry. Pharmacies in Ivory Coast have responded to this trend by expanding their range of natural and herbal remedies, and promoting them as a healthier option for customers. Another trend in the market is the growing popularity of combination cold and cough remedies. These products offer a convenient solution for customers who are experiencing multiple symptoms, such as congestion, coughing, and sore throat. Combination remedies provide relief for multiple symptoms in a single product, which saves customers the hassle of purchasing and taking multiple medications. This trend is driven by customer demand for convenience and efficiency.

Local special circumstances:
In Ivory Coast, the prevalence of cold and cough symptoms is relatively high due to the country's tropical climate. The hot and humid weather conditions create an environment that is conducive to the spread of respiratory infections. As a result, there is a higher demand for cold and cough remedies compared to countries with milder climates. Additionally, the high population density in urban areas of Ivory Coast contributes to the spread of respiratory infections, further driving the demand for these remedies.

Underlying macroeconomic factors:
The growing Cold & Cough Remedies market in Ivory Coast can also be attributed to the country's overall economic development. Ivory Coast has experienced steady economic growth in recent years, leading to an increase in disposable income among the population. As a result, more people are able to afford healthcare products, including cold and cough remedies. Furthermore, the expansion of the healthcare sector in Ivory Coast, including the establishment of more pharmacies and healthcare facilities, has made these remedies more accessible to the population. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Ivory Coast is developing due to customer preferences for convenient access to over-the-counter remedies, the rising popularity of natural and herbal remedies, and the demand for combination products. The country's tropical climate and high population density contribute to the prevalence of cold and cough symptoms. Furthermore, the country's economic development and expansion of the healthcare sector have made these remedies more accessible to the population.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)